AGP Executive Report
Last update: 7 hours agoParkinson’s Drug Update: BioVie reported positive Phase 2 SUNRISE-PD topline results for bezisterim, showing statistically significant improvements in both motor and nonmotor symptoms in early Parkinson’s. Medicare Access: Amazon Pharmacy launched GLP-1 delivery for eligible Medicare patients under CMS’s Medicare GLP-1 Bridge Program, aiming to cut paperwork and prior-authorization delays. Stargardt Deal: Tarsus Pharmaceuticals agreed to buy Alkeus Pharmaceuticals for about $450M to advance gildeuretinol, an oral therapy in Stargardt disease. Infection Alert: CDC data says the drug-resistant fungus Candida auris is spreading across U.S. healthcare settings, including confirmed cases in Kentucky. Cybersecurity: A new Europe-30 index flags major hospital cyber-risk pressure in Poland, the UK, France and Germany, driven by ransomware and recovery friction. Workforce & Care Delivery: Texas announced $5.6M in nursing education grants; Canada’s hospital funding crunch report highlights Ontario’s Huron Perth Healthcare Alliance deficits. Maternal Health: A Kaduna faith-based campaign is pushing child spacing and antenatal care through mosques and churches.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
